V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007797 | 310011950 | 1.78 | 79.3 | Palliative (P) | null | 2014-09-12 | PEG INTERFERON | 1 | N | 310019603 | HCX |
| 310007798 | 310011958 | 1.79 | 90.2 | Disease modification (D) | 2016-06-22 | 2016-06-22 | TOPOTECAN | N | N | 310019609 | FLUOROURACIL + MITOMYCIN |
| 310007799 | 310004983 | 1.76 | 92.4 | Curative (C) | 2016-11-05 | 2017-03-05 | Dacarbazine | N | N | 310019610 | CAV |
| 310007800 | 310004983 | 1.51 | 71 | Palliative (P) | 2016-09-25 | 2016-10-01 | MCX | 02 | N | 310019610 | CAPECITABINE + MITOMYCIN + RT |
| 310007801 | 310004983 | 1.77 | 77.35 | Palliative (P) | 2015-07-09 | 2015-07-14 | IVAC | N | N | 310019610 | PEG INTERFERON |
| 310007802 | 310008165 | 1.81 | 54.9 | Palliative (P) | 2015-11-22 | 2015-11-29 | PEG INTERFERON | N | N | 310019617 | CISPLATIN + ETOPOSIDE |
| 310007803 | 310004987 | 1.6 | 49.1 | Curative (C) | 2014-06-21 | 2014-06-30 | Atezolizumab | N | N | 310019624 | BCG |
| 310007804 | 310004988 | 1.77 | 67.6 | null | 2013-03-22 | 2013-07-17 | PEG INTERFERON | N | N | 310019631 | GEMCITABINE + OXALIPLATIN |
| 310007805 | 310004989 | null | null | null | 2018-02-06 | 2018-05-30 | Mitomycin Intravesical | N | N | 310019634 | DOXORUBICIN |
| 310007806 | 310004989 | 1.66 | 76 | Curative (C) | 2016-09-01 | 2016-09-29 | Atezolizumab | null | N | 310019634 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310007807 | 310004989 | 1.77 | 118 | null | 2013-12-17 | 2013-12-18 | Cytarabine+Methotrexate Intrathecal | 2 | N | 310019634 | CISPLATIN + ETOPOSIDE |
| 310007808 | 310011835 | 1.63 | 8.8 | Palliative (P) | 2018-05-28 | 2018-06-25 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | Y | 310019645 | TRASTUZUMAB |
| 310007809 | 310011835 | 1.54 | 53.6 | null | 2015-03-11 | 2015-03-12 | DABRAFENIB + TRAMETINIB | N | N | 310019645 | CISPLATIN + TOPOTECAN |
| 310007810 | 310004991 | 0 | 84.3 | Curative (C) | 2016-08-05 | 2017-10-27 | ATG + Busulfan + Fludarabine + Thiotepa | N | N | 310019658 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 310007811 | 310004991 | 1.86 | 88.1 | Palliative (P) | 2018-02-09 | 2018-02-09 | TIP | N | N | 310019658 | BCG |
| 310007812 | 310009844 | 1.58 | 70.1 | Curative (C) | 2017-01-13 | 2017-01-15 | Pemetrexed | N | N | 310019663 | MITOMYCIN |
| 310007813 | 310009844 | 1.6 | 70.2 | Disease modification (D) | 2013-07-19 | 2013-08-02 | Oxaliplatin + Modified de Gramont | 02 | N | 310019663 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 310007814 | 310004992 | 1.7 | null | Curative (C) | 2015-03-12 | 2015-03-13 | CISPLATIN + FLUOROURACIL | N | null | 310019667 | MITOMYCIN INTRAVESICULAR |
| 310007815 | 310004993 | null | 23.6 | Palliative (P) | 2016-09-13 | 2016-09-13 | VEDex | N | N | 310019672 | BEVACIZUMAB + CARBO |
| 310007816 | 310004993 | null | 90.8 | Palliative (P) | 2018-01-29 | 2018-01-29 | FLUOROURACIL + OXALIPLATIN | null | null | 310019672 | RCEOP |
| 310007817 | 310004994 | null | 95.3 | Neo-adjuvant (N) | 2015-01-06 | 2015-02-11 | AXI-STS TRIAL | N | null | 310019674 | VEMURAFENIB |
| 310007818 | 310004994 | 1.76 | 50 | null | 2015-03-02 | 2015-03-28 | ECHELON-2 TRIAL | 02 | N | 310019674 | TRIPLE INTRATHECAL |
| 310007819 | 310011280 | 1.68 | 0 | Curative (C) | 2014-01-03 | 2014-01-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 02 | N | 310019677 | ECX |
| 310007820 | 310009848 | 1.53 | 72.8 | Curative (C) | 2014-10-15 | 2014-10-15 | NIVOLUMAB | 02 | N | 310019677 | CAPECITABINE + OXALIPLATIN |
| 310007821 | 310005005 | 1.73 | 88.6 | Curative (C) | 2015-02-06 | 2015-02-14 | DHAP | 02 | N | 310019687 | HCX |
| 310007822 | 310005006 | 1.57 | 59.3 | Curative (C) | 2017-06-24 | 2017-06-25 | Abiraterone | 02 | null | 310019692 | PEMETREXED |
| 310007824 | 310005010 | 1.58 | 81.8 | Curative (C) | 2016-03-15 | 2016-03-16 | Olaparib | N | N | 310019697 | CAPECITABINE |
| 310007825 | 310008177 | 1.75 | null | Palliative (P) | 2014-04-12 | 2014-04-14 | Capecitabine + Oxaliplatin 21day | N | N | 310019710 | VEMURAFENIB |
| 310007826 | 310005014 | 1.73 | 103.6 | Curative (C) | 2016-09-08 | 2016-09-08 | DABRAFENIB | N | N | 310019710 | ALEMTUZUMAB |
| 310007827 | 310005016 | 1.59 | 57.5 | Curative (C) | 2014-02-26 | 2014-02-27 | Capecitabine | 2 | N | 310019720 | CISPLATIN + ETOPOSIDE |
| 310007828 | 310005017 | 1.48 | 76 | Not known (9) | 2014-09-30 | 2014-10-25 | Hydroxycarbamide | N | N | 310019722 | CAPECITABINE |
| 310007829 | 310005018 | 1.74 | 89 | Palliative (P) | 2015-06-23 | 2015-07-06 | Alemtuzumab | N | N | 310019722 | VINBLASTINE |
| 310007830 | 310005019 | 1.45 | 54.5 | Curative (C) | 2013-11-04 | 2013-11-04 | IVE + METHOTREXATE | 02 | N | 310019727 | MPV |
| 310007831 | 310005020 | 1.69 | 86.6 | Palliative (P) | 2017-08-05 | 2018-03-12 | OCTOPUS Trial | null | N | 310019730 | CVD |
| 310007832 | 310008181 | 1.85 | 66.8 | null | null | 2016-10-03 | CISPLATIN + FLUOROURACIL | 2 | N | 310019735 | MELPHALAN + TOPOTECAN |
| 310007833 | 310005021 | null | null | Adjuvant (A) | 2017-03-18 | 2017-03-19 | Alemtuzumab(INTRAVENOUS) | N | null | 310019738 | VEMURAFENIB |
| 310007834 | 310008183 | null | 26.4 | Curative (C) | 2017-06-07 | 2017-07-09 | Cabazitaxel | N | N | 310019742 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 310007835 | 310005023 | null | 106.7 | Curative (C) | 2014-07-26 | 2014-07-26 | ICON8B TRIAL | 2 | Y | 310019750 | CARBOPLATIN + PEMETREXED |
| 310007837 | 310008186 | 1.64 | 50 | Palliative (P) | 2015-02-18 | 2015-09-03 | IVE + METHOTREXATE | N | N | 310019753 | CVD |
| 310007838 | 310008186 | 1.57 | 78.7 | Palliative (P) | 2017-12-07 | 2017-12-07 | Pemetrexed | N | N | 310019753 | DABRAFENIB |
| 310007840 | 310008187 | 1.59 | null | Curative (C) | 2013-01-08 | 2013-03-27 | Oxaliplatin + Modified de Gramont | N | N | 310019761 | CISPLATIN + FLUOROURACIL + RT |
| 310007841 | 310008187 | null | null | Curative (C) | 2014-12-11 | 2014-12-11 | Trastuzumab Subcutaneous | 02 | null | 310019761 | CARBO + FLUOROURACIL |
| 310007842 | 310008187 | null | null | Curative (C) | 2016-07-02 | 2016-06-15 | Carboplatin + Pemetrexed | null | null | 310019761 | IFOSFAMIDE |
| 310007843 | 310008187 | 1.59 | 63.3 | Curative (C) | 2017-10-23 | 2017-12-12 | Doxorubicin 75mg/m2 | N | null | 310019761 | BORTEZOMIB |
| 310007844 | 310005029 | 1.68 | 55.8 | Curative (C) | 2016-03-09 | 2016-04-11 | CARBOPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + PACLITAXEL | N | N | 310019770 | GEFITINIB |
| 310007845 | 310005029 | null | 65.4 | Palliative (P) | 2017-09-24 | 2017-09-24 | ICON8 TRIAL | 02 | null | 310019770 | OXALIPLATIN + MDG |
| 310007846 | 310005030 | 1.67 | 67.2 | Palliative (P) | 2016-06-09 | 2016-06-11 | Chlorambucil | N | N | 310019773 | DOXORUBICIN + IFOSFAMIDE + VINCRISTINE |
| 310007847 | 310005030 | 1.67 | 85 | Curative (C) | 2017-04-24 | 2017-04-26 | MITOMYCIN | 02 | N | 310019773 | GEMCITABINE + OXALIPLATIN |
| 310007849 | 310005033 | null | null | Curative (C) | 2014-08-03 | 2014-09-01 | Cisplatin + Pemetrexed | null | null | 310019783 | TRASTUZUMAB |
| 310007850 | 310005033 | 1.84 | 96.8 | null | 2015-11-15 | 2015-11-26 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE | N | N | 310019783 | ICE |